Founders & Management Team:
Dr. Emily Carter (CEO), a nutritionist, and Tom Nguyen (COO), a beverage industry veteran, lead this project. The team includes product developers and marketing professionals.
History of Past Funding Requests:
In 2021, the founders raised €200,000 in seed funding to develop the first product line and establish the plant. The funds were used for product development (€120,000) and initial equipment purchases (€80,000).
Business Case:
The global functional beverage market is growing rapidly, driven by consumer demand for health-conscious alternatives to sugary drinks. Our vitamin-enriched water offers hydration with added health benefits, targeting a broad audience from athletes to health-conscious individuals. The global functional beverage market is projected to grow to €145 billion by 2026.
Shareholding Structure:
The founders hold 65% of the company (Emily: 35%, Tom: 30%), with the remaining 35% held by early investors.
Marketing Strategy:
We will launch a digital marketing campaign targeting health-conscious consumers on Instagram, YouTube, and Facebook. Influencer marketing and partnerships with gyms and health clubs will also drive awareness.
Risk Mitigation:
Raw material sourcing and regulatory compliance are potential risks. We mitigate this by securing long-term supplier contracts and ensuring our products meet all regulatory standards in advance.
Social Impact:
Our plant-based, vitamin-enriched water helps reduce reliance on sugary beverages, contributing to healthier communities. We also use eco-friendly packaging to minimize our environmental impact.
Type of Investment Needed:
Equity investment to scale production and marketing efforts.
Funding Amount Required:
€350,000
Use of Funds:
- Production and bottling equipment: €100,000
- Raw material sourcing: €80,000
- Packaging and branding: €70,000
- Marketing and influencer partnerships: €50,000
- Regulatory compliance: €50,000
Expected ROI:
20-25%, driven by growing consumer demand for functional beverages.
Payback Period:
3 years, with profitability expected in year one.